Verition Fund Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-367,671
Closed -$42.5M 2848
2023
Q3
$42.5M Buy
367,671
+7,477
+2% +$803K 0.57% 23
2023
Q2
$37M Sell
360,194
-525,002
-59% -$55.4M 0.58% 27
2023
Q1
$96.6M Buy
885,196
+479,372
+118% +$53M 1.54% 2
2022
Q4
$46.2M Buy
405,824
+310,321
+325% +$25.8M 0.9% 13
2022
Q3
$5.91M Buy
95,503
+85,920
+897% +$6M 0.08% 360
2022
Q2
$764K Sell
9,583
-3,381
-26% -$320K 0.02% 1179
2022
Q1
$1.36M Buy
12,964
+37
+0.3% +$3.61K 0.03% 1261
2021
Q4
$1.39M Buy
+12,927
New +$1.41M 0.02% 1093
2020
Q4
Sell
-5,231
Closed -$406K 1582
2020
Q3
$406K Buy
+5,231
New +$360K 0.01% 658
2015
Q3
Sell
-15,246
Closed -$530K 820
2015
Q2
$530K Buy
+15,246
New +$465K 0.12% 176
2014
Q4
Sell
-44,343
Closed -$545K 758
2014
Q3
$545K Buy
+44,343
New +$515K 0.1% 216
2014
Q1
Sell
-11,987
Closed -$91K 706
2013
Q4
$91K Buy
+11,987
New +$64.6K 0.02% 453

Other funds holding HZNP